首页|少腹逐瘀汤联合亮丙瑞林治疗子宫腺肌病术后患者的效果

少腹逐瘀汤联合亮丙瑞林治疗子宫腺肌病术后患者的效果

扫码查看
目的:观察少腹逐瘀汤联合亮丙瑞林治疗子宫腺肌病术后患者的效果.方法:回顾性分析2021—2023年该院收治的61例子宫腺肌病手术患者的临床资料,依据治疗方式不同将其分为研究组(n=30)和对照组(n=31).对照组给予亮丙瑞林治疗,研究组在对照组基础上联合少腹逐瘀汤治疗,比较两组临床疗效,治疗前后痛经程度[COX痛经症状评分量表(CMSS)]评分、疾病相关指标[糖类抗原125(CA125)、卵泡刺激素(FSH)、雌二醇(E2)]水平,以及不良反应发生率.结果:研究组治疗总有效率为90.00%,高于对照组的67.74%,差异有统计学意义(P<0.05);两组严重程度、持续时间等CMSS评分均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);两组CA125、FSH、E2水平均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);研究组不良反应发生率低于对照组,差异有统计学意义(P<0.05).结论:少腹逐瘀汤联合亮丙瑞林治疗子宫腺肌病术后患者可提高治疗总有效率,降低痛经程度评分、疾病相关指标水平和不良反应发生率的效果优于单纯亮丙瑞林治疗.
Effects of Shaofu Zhuyu decoction combined with Leuprorelin in treatment of postoperative patients with adenomyosis
Objective:To observe effects of Shaofu Zhuyu decoction combined with Leuprorelin in treatment of postoperative patients with adenomyosis. Methods:The clinical data of 61 patients with adenomyosis who underwent surgery in this hospital from 2021 to 2023 were retrospectively analyzed. According to different treatment methods,they were divided into study group (n=30) and control group (n=31). The control group was treated with Leuprorelin,while the study group was treated with Shaofu Zhuyu decoction on the basis of that of the control group. The clinical efficacy,the degree of dysmenorrhea[COX menstrual symptom scale (CMSS)]score and the disease-related indicators[carbohydrate antigen 125 (CA125),follicle stimulating hormone (FSH),estradiol (E2)]levels before and after the treatment,and the incidence of adverse reactions were compared between the two groups. Results:The total effective rate of treatment in the study group was 90.00%,which was higher than 67.74% in the control group,and the difference was statistically significant (P<0.05). The CMSS scores such as severity and duration of the two groups were lower than those before the treatment,that in the study group was lower than that in the control group,and the differences were statistically significant (P<0.05). The levels of CA125,FSH and E2 in the two groups were lower than those before treatment,those in the study group were lower than those in the control group,and the differences were statistically significant (P<0.05). Further,the incidence of adverse reactions in the study group was lower than that in the control group,and the difference was statistically significant (P<0.05). Conclusions:Shaofu Zhuyu decoction combined with Leuprorelin in the treatment of the postoperative patients with adenomyosis can improve the total effective rate of treatment and reduce the scores of dysmenorrhea degree,the levels of disease-related indicators and the incidence of adverse reactions. Moreover,it is superior to simple Leuprorelin treatment.

Shaofu Zhuyu decoctionLeuprorelinAdenomyosisDysmenorrhea degreeAdverse reaction

贾海金

展开 >

山东省泰安市妇幼保健院,山东 泰安 271000

少腹逐瘀汤 亮丙瑞林 子宫腺肌病 痛经程度 不良反应

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(23)